Delivery Order SPE2DB22D1200-SPE2DB25FN2PT

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.88 contract is for the supply of JATENZO 198 MG CAPSULE 120S, a medication, to be delivered by June 10, 2025. This order is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set-aside, is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $2,263.74. The period of performance extends to May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug product JATENZO 237 MG CAPSULE 120S. The award has a ceiling value of $1,131.87 and a completion date of June 5, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a prescription medication. The contract has a firm fixed price of $2,406.07 and a performance period ending on May 14, 2025. The contract is not set aside and was awarded on May 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a $3,401.72 delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of JATENZO 237 MG CAPSULE 120S, a medical product, to support federal medical procurement needs. The contract has a firm fixed price pricing type and an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the medication JATENZO 237 MG CAPSULE 120S. The contract has a firm fixed price, a ceiling value of $2,263.74, and a period of performance ending on May 22, 2025. The contract is not set aside and was awarded on May 21, 2025. AmerisourceBergen Drug Corp is the prime contractor for this delivery order, which is part of a larger...
This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the supply of the pharmaceutical product JATENZO 237 MG CAPSULE 120S. The firm-fixed-price contract has a ceiling value of $2,781.84 and an ultimate completion date of May 21, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,492.24 firm fixed-price delivery order is for the supply of 120 capsules of the prescription drug JATENZO 198 MG. The contract has an ultimate completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $1,263.74, is for the delivery of the medication JATENZO 198MG CAP 120S to support military treatment programs and facilities. The contract has a period of performance through March 22, 2024 and does not utilize any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,154.01 firm fixed-price delivery order is for the supply of 120 units of the medication JATENZO 237 MG CAPSULE. The award has an ultimate completion date of May 7, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB25FN2PT
    Delivery Order

This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,317.93, is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of June 18, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order contract is part of the company's broader contract relationship with the DLA, through which it supplies a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract is not designated as a set-aside.

Generated 9/16/25, 9:50 AM